Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
1.670
+0.260 (18.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tenaya Therapeutics Employees
Tenaya Therapeutics had 140 employees as of December 31, 2023. The number of employees decreased by 1 or -0.71% compared to the previous year.
Employees
140
Change (1Y)
-1
Growth (1Y)
-0.71%
Revenue / Employee
n/a
Profits / Employee
-$837,343
Market Cap
132.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 140 | -1 | -0.71% |
| Dec 31, 2022 | 141 | 35 | 33.02% |
| Dec 31, 2021 | 106 | 31 | 41.33% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 265 |
| TELA Bio | 227 |
| Zomedica | 144 |
| Allakos | 131 |
| Cabaletta Bio | 103 |
| Lineage Cell Therapeutics | 75 |
| Milestone Pharmaceuticals | 47 |
| Sensus Healthcare | 35 |
TNYA News
- 5 days ago - Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 - GlobeNewsWire
- 6 weeks ago - Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM - GlobeNewsWire
- 3 months ago - Tenaya Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire
- 6 months ago - Tenaya Therapeutics Announces Research Leadership Updates - GlobeNewsWire
- 6 months ago - Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit - GlobeNewsWire
- 7 months ago - Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 8 months ago - Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting - GlobeNewsWire